Distributions of all expression values and Top 1% of expressed KnownBoundary features for libraries: MDS019_T1, MDS019_T2, MDS019

Distributions of all expression values and Top 1% of expressed KnownBoundary features for libraries: MDS019_T1, MDS019_T2, MDS019_T3

Download data matrix file (KnownBoundary x library): KnownBoundaryExpression_v60.txt.gz

Distribution of log2 expression values for library: MDS019_T1 and data type: KnownBoundary

Distribution of all expression values for the feature type: KnownBoundary. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here

Distribution of log2 expression values for library: MDS019_T2 and data type: KnownBoundary

Distribution of log2 expression values for library: MDS019_T3 and data type: KnownBoundary

Top 1% of expressed KnownBoundary features

The following table provides a ranked list of the most highly expressed KnownBoundary features. Each column corresponds to an expression library. Each table cell contains the Gene Name (which links to the ALEXA-Seq gene record), followed by the Feature Name (which links to the feature's coordinates in the UCSC Genome Browser and displays expression data), the log2 expression value 'Exp' for the feature, and the percent expression value '% Exp' ([feature expression/gene expression]*100). For Gene records the percent displayed here represents the percentage of all reads for the library instead. Features that are NOT supported by an EST/mRNA sequence are indicated in bold. For exon junction features the number of exons skipped by the junction is indicated as 'Sn', where n is the number of exons skipped (e.g. S0 means no exons skipped, S1 means one exon skipped, etc.).

RANK	MDS019_T1 (Gene \| Feature \| Exp \| % Exp)	MDS019_T2 (Gene \| Feature \| Exp \| % Exp)	MDS019_T3 (Gene \| Feature \| Exp \| % Exp)
1	AC011247.2 \| E1_Ab \| 17.44 \| 538182.46%	AC011247.2 \| E1_Ab \| 18.14 \| 474674.29%	AC011247.2 \| E1_Ab \| 17.34 \| 596973.07%
2	RPL18A \| E3_Da \| 16.67 \| 260.02%	GAPDH \| E2_Ae \| 17.14 \| 627.61%	GAPDH \| E2_Ae \| 17.24 \| 500.87%
3	GAPDH \| E2_Ae \| 16.51 \| 500.91%	RPL18A \| E3_Da \| 17.00 \| 312.51%	RPS24 \| E3_Da \| 17.01 \| 2327.47%
4	RPS24 \| E3_Da \| 16.48 \| 1690.66%	RPL10 \| E6_Ae \| 16.85 \| 1430.76%	RPL18A \| E3_Da \| 16.91 \| 245.54%
5	RPS4X \| E6_Ab \| 16.32 \| 619.86%	HSP90AB1 \| E4_Da \| 15.97 \| 592.12%	RPL10 \| E6_Ae \| 16.50 \| 1403.24%
6	RPL10 \| E6_Ae \| 16.15 \| 1267.20%	EEF1A1P12 \| E1_Ab \| 15.89 \| 741866.59%	RPS3A \| E1_Ak \| 16.40 \| 950.05%
7	RPS3A \| E1_Ak \| 15.97 \| 814.55%	TPT1 \| E1_Ae \| 15.76 \| 294.82%	RPS4X \| E6_Ab \| 16.36 \| 601.57%
8	HBB \| E3_Ac \| 15.91 \| 428.15%	TPT1 \| E1_Aj \| 15.74 \| 289.95%	CD74 \| E8_Ac \| 16.26 \| 404.75%
9	RPS20 \| E1_Ae \| 15.86 \| 937.11%	RPL13A \| E2_Af \| 15.66 \| 178.23%	ACTB \| E6_Dc \| 16.01 \| 191.05%
10	HSP90AB1 \| E4_Da \| 15.85 \| 522.68%	RPL30 \| E7_Ad \| 15.66 \| 1076.87%	RPS7 \| E1_Ah \| 15.96 \| 2789.93%
11	EEF1A1P12 \| E1_Ab \| 15.80 \| 626766.46%	RP4-756H11.2 \| E1_Ac \| 15.62 \| 353837.79%	EEF1A1P12 \| E1_Ab \| 15.95 \| 602846.04%
12	RPL30 \| E7_Ad \| 15.68 \| 1069.65%	AC011247.2 \| E1_Ac \| 15.43 \| 72132.11%	RPS20 \| E1_Ae \| 15.94 \| 1025.95%
13	RPS6 \| E1_Dd \| 15.59 \| 465.97%	RPS4X \| E6_Ab \| 15.40 \| 484.27%	RPS3A \| E3_Db \| 15.91 \| 677.94%
14	RP4-756H11.2 \| E1_Ac \| 15.48 \| 87722.16%	ACTB \| E6_Dc \| 15.37 \| 214.39%	RPL30 \| E7_Ad \| 15.89 \| 1163.62%
15	ACTB \| E6_Dc \| 15.43 \| 163.60%	RPS3A \| E1_Ak \| 15.36 \| 815.07%	GAPDH \| E6_Ab \| 15.87 \| 193.31%
16	NPM1 \| E2_Ag \| 15.34 \| 861.96%	TPT1 \| E1_Ad \| 15.33 \| 218.46%	HSP90AB1 \| E4_Da \| 15.71 \| 560.70%
17	RPS21 \| E2_Ac \| 15.31 \| 549.07%	RPS20 \| E1_Ae \| 15.29 \| 929.73%	RPS6 \| E1_Dd \| 15.66 \| 571.19%
18	ACTB \| E6_Db \| 15.24 \| 143.33%	RPS21 \| E2_Ac \| 15.24 \| 553.00%	HLA-DRA \| E1_Ad \| 15.64 \| 162.66%
19	RPS7 \| E1_Ah \| 15.21 \| 2525.19%	ACTB \| E6_Db \| 15.22 \| 193.31%	TPT1 \| E1_Aj \| 15.60 \| 319.95%
20	GAPDH \| E6_Ab \| 15.17 \| 197.73%	CD74 \| E8_Ac \| 15.22 \| 282.14%	RP4-756H11.2 \| E1_Ac \| 15.59 \| 90037.95%
21	GAPDH \| E5_Dj \| 15.16 \| 196.45%	NPM1 \| E2_Ag \| 15.13 \| 989.96%	AC011247.2 \| E1_Ac \| 15.57 \| 174813.31%
22	RPS3A \| E3_Db \| 15.12 \| 454.19%	GAPDH \| E6_Ab \| 15.09 \| 152.26%	RPS8 \| E3_Dd \| 15.55 \| 507.37%
23	AC100786.1 \| E1_Da \| 15.10 \| 58.51%	RPL14 \| E2_Ad \| 15.09 \| 1200.06%	NPM1 \| E2_Ag \| 15.44 \| 946.36%
24	RPS8 \| E3_Dd \| 15.07 \| 403.61%	TPT1 \| E1_Dc \| 15.07 \| 182.71%	ACTB \| E6_Db \| 15.42 \| 126.92%
25	EEF1A1 \| E4_Da \| 15.03 \| 575.64%	RPS6 \| E1_Dd \| 15.01 \| 335.58%	HLA-DRA \| E2_Ab \| 15.41 \| 139.13%
26	TPT1 \| E1_Aj \| 15.03 \| 319.47%	RPS7 \| E1_Ah \| 14.90 \| 2574.93%	GAPDH \| E5_Dj \| 15.40 \| 139.75%
27	AC011247.2 \| E1_Ac \| 15.02 \| 100721.86%	GAPDH \| E5_Dj \| 14.88 \| 131.68%	AC100786.1 \| E1_Da \| 15.34 \| 68.69%
28	EEF1A1 \| E4_Dh \| 14.96 \| 550.02%	ACTB \| E6_Dl \| 14.85 \| 148.83%	EEF1A1 \| E4_Da \| 15.28 \| 608.17%
29	ACTB \| E6_Dl \| 14.96 \| 118.55%	RPS3A \| E3_Da \| 14.81 \| 556.76%	TUBA1C \| E5_Ab \| 15.24 \| 1880.20%
30	RPL14 \| E2_Ad \| 14.93 \| 1057.92%	HBB \| E3_Ac \| 14.81 \| 481.24%	EEF1A1 \| E4_Dh \| 15.22 \| 580.46%
31	RPS3A \| E3_Da \| 14.90 \| 389.28%	CTD-2192J16.15 \| E1_Db \| 14.80 \| 87780.27%	ATP5J2 \| E4_Da \| 15.21 \| 593.12%
32	NPM1 \| E4_Da \| 14.88 \| 624.38%	RPS24 \| E3_Da \| 14.80 \| 1255.71%	NPM1 \| E4_Da \| 15.19 \| 797.89%
33	RPL13A \| E2_Af \| 14.84 \| 126.07%	RPL14 \| E4_Da \| 14.78 \| 966.13%	TPT1 \| E1_Dc \| 15.12 \| 229.76%
34	NPM1 \| E2_Ah \| 14.82 \| 599.32%	RPS27A \| E3_Dc \| 14.76 \| 1085.45%	ACTB \| E6_Dl \| 15.12 \| 103.28%
35	CTD-2192J16.15 \| E1_Db \| 14.81 \| 140569.44%	RPS21 \| E3_Df \| 14.72 \| 386.56%	TPT1 \| E1_Ae \| 15.11 \| 228.00%
36	RPS23 \| E3_Da \| 14.80 \| 1207.10%	SLC25A5 \| E1_Da \| 14.72 \| 663.91%	ACTB \| E6_Dd \| 15.11 \| 102.67%
37	RPS14 \| E1_Ah \| 14.78 \| 855.33%	CTD-2124B20.1 \| E1_Da \| 14.64 \| 352464.96%	RPS21 \| E2_Ac \| 15.11 \| 577.79%
38	ACTB \| E6_Dd \| 14.77 \| 103.96%	CD74 \| E8_Db \| 14.59 \| 182.70%	RPL14 \| E2_Ad \| 15.09 \| 1079.95%
39	RPL23 \| E6_Da \| 14.76 \| 623.02%	EEF1A1 \| E4_Dh \| 14.57 \| 462.24%	ACTB \| E7_Ab \| 15.09 \| 100.97%
40	ACTB \| E7_Ab \| 14.72 \| 100.37%	CD53 \| E1_Ad \| 14.56 \| 674.84%	CD74 \| E8_Db \| 15.04 \| 173.83%
41	ATP5J2 \| E4_Da \| 14.70 \| 564.73%	ACTB \| E6_Dd \| 14.50 \| 117.24%	RPL23 \| E6_Da \| 14.98 \| 618.92%
42	CD74 \| E8_Ac \| 14.69 \| 374.34%	CD74 \| E1_Ag \| 14.50 \| 170.98%	GNB2L1 \| E3_Ap \| 14.95 \| 779.50%
43	RPS27A \| E3_Dc \| 14.68 \| 798.69%	RPL32 \| E2_Da \| 14.49 \| 524.82%	RPSAP58 \| E6_Ab \| 14.94 \| 1353.24%
44	ACTB \| E6_Di \| 14.67 \| 97.16%	HLA-C \| E1_Ag \| 14.46 \| 819.79%	CTD-2192J16.15 \| E1_Db \| 14.93 \| 181266.91%
45	RPS21 \| E3_Df \| 14.66 \| 349.83%	SLC25A5 \| E3_Ab \| 14.46 \| 556.20%	ACTB \| E6_Dj \| 14.92 \| 90.01%
46	RPL14 \| E4_Da \| 14.52 \| 798.69%	RP4-756H11.2 \| E1_Da \| 14.46 \| 157704.02%	RP11-1113N2.2 \| E1_Ac \| 14.78 \| 978872.52%
47	ACTB \| E6_Dj \| 14.50 \| 85.90%	RPL23 \| E6_Da \| 14.38 \| 636.12%	HMGB1 \| E5_Ae \| 14.77 \| 790.97%
48	RPL29 \| E3_Da \| 14.49 \| 236.02%	NPM1 \| E2_Ah \| 14.38 \| 590.79%	ACTB \| E6_Di \| 14.77 \| 80.90%
49	TPT1 \| E1_Ae \| 14.49 \| 219.70%	SH3BGRL3 \| E2_Db \| 14.38 \| 490.73%	RPS3A \| E3_Da \| 14.75 \| 302.95%
50	TUBA1C \| E5_Ab \| 14.48 \| 1031.27%	HLA-DRA \| E1_Ad \| 14.34 \| 157.41%	RPL14 \| E4_Da \| 14.75 \| 850.30%
51	CTD-2124B20.1 \| E1_Da \| 14.47 \| 105309.03%	RPS23 \| E3_Da \| 14.33 \| 1215.05%	ATP5E \| E1_Ac \| 14.74 \| 2277.03%
52	NCRNA00188 \| E1_Al \| 14.45 \| 964.95%	SNX17 \| E1_Ah \| 14.33 \| 1558.87%	TUBB \| E5_Db \| 14.74 \| 192.42%
53	RPL32 \| E2_Da \| 14.45 \| 321.58%	CASP4 \| E3_Da \| 14.32 \| 1232.60%	TPT1 \| E1_Ad \| 14.73 \| 174.75%
54	HMGB1 \| E5_Ae \| 14.40 \| 589.71%	RPS14 \| E1_Ah \| 14.30 \| 972.85%	CD74 \| E1_Ag \| 14.70 \| 137.27%
55	COX7C \| E1_Af \| 14.39 \| 820.28%	TUT1 \| E12_Da \| 14.30 \| 469.88%	RPL23 \| E6_Db \| 14.70 \| 507.82%
56	HBB \| E4_Da \| 14.37 \| 146.68%	HLA-DRA \| E2_Ab \| 14.30 \| 152.60%	RPS23 \| E3_Da \| 14.69 \| 1410.05%
57	RP4-756H11.2 \| E1_Da \| 14.36 \| 40453.59%	SLC25A6 \| E1_Ae \| 14.27 \| 397.67%	GAPDH \| E5_Dh \| 14.69 \| 85.03%
58	TPT1 \| E1_Dc \| 14.36 \| 201.41%	ACTB \| E6_Di \| 14.27 \| 99.53%	RPS27A \| E3_Dc \| 14.65 \| 729.18%
59	PABPC1 \| E1_Ah \| 14.30 \| 339.15%	TOMM7 \| E1_Ae \| 14.21 \| 996.59%	CTD-2124B20.1 \| E1_Da \| 14.62 \| 136223.20%
60	TXN \| E1_Ab \| 14.26 \| 446.88%	RPS20 \| E1_Dh \| 14.19 \| 435.17%	RPL13A \| E2_Af \| 14.61 \| 101.81%
61	GNB2L1 \| E3_Ap \| 14.22 \| 541.73%	RPL4 \| E4_Da \| 14.19 \| 141.79%	NPM1 \| E2_Ah \| 14.59 \| 524.72%
62	RPS3A \| E4_Db \| 14.22 \| 242.68%	PABPC1 \| E7_Ad \| 14.18 \| 357.21%	BTF3 \| E1_Ah \| 14.57 \| 686.88%
63	RPL4 \| E9_Ab \| 14.22 \| 132.71%	EEF1B2 \| E1_Ak \| 14.17 \| 589.33%	SH3BGRL3 \| E2_Db \| 14.50 \| 475.95%
64	TOMM7 \| E1_Ae \| 14.22 \| 981.50%	ACTB \| E6_Dj \| 14.16 \| 92.53%	TUBB \| E5_Ab \| 14.45 \| 157.61%
65	RP11-1113N2.2 \| E1_Ac \| 14.21 \| 133692.90%	RPL4 \| E9_Ab \| 14.14 \| 137.57%	COX7C \| E1_Af \| 14.42 \| 880.30%
66	TPT1 \| E1_Ad \| 14.20 \| 180.74%	HIST1H2BK \| E1_Ab \| 14.13 \| 701.31%	HLA-DRA \| E3_Db \| 14.39 \| 68.55%
67	PABPC1 \| E7_Ad \| 14.17 \| 310.23%	AC100778.1 \| E2_Ab \| 14.12 \| 237.20%	ACTB \| E6_Ah \| 14.38 \| 61.70%
68	ACTB \| E6_Ah \| 14.17 \| 68.60%	RPS8 \| E3_Dd \| 14.12 \| 225.42%	RPL4 \| E10_Ab \| 14.37 \| 131.59%
69	HNRPA1L3 \| E1_Dd \| 14.13 \| 40130.16%	EEF1A1 \| E4_Da \| 14.07 \| 326.79%	CD99 \| E1_Ae \| 14.37 \| 470.23%
70	ACTB \| E6_Dm \| 14.09 \| 64.65%	ATP5J2 \| E4_Da \| 14.06 \| 456.40%	HLA-DQA1 \| E4_Ah \| 14.35 \| 3391.89%
71	RPS20 \| E1_Dh \| 14.08 \| 271.32%	RPLP0 \| E2_Ab \| 14.06 \| 31.64%	HLA-DRA \| E3_Ab \| 14.34 \| 66.25%
72	PABPC1 \| E10_Da \| 14.07 \| 288.56%	SNRPD3 \| E3_Da \| 14.06 \| 1033.96%	GAPDH \| E5_Ah \| 14.33 \| 66.52%
73	DENND1B \| E4_Da \| 14.07 \| 72596.38%	ATP5E \| E1_Ac \| 14.05 \| 2174.74%	PABPC1 \| E7_Ad \| 14.32 \| 322.34%
74	EEF1B2 \| E1_Ak \| 14.06 \| 524.82%	AC073621.1 \| E1_Ab \| 14.05 \| 38182.41%	GAPDH \| E5_Di \| 14.32 \| 66.00%
75	LDHB \| E1_Ad \| 14.05 \| 289.95%	NCRNA00188 \| E1_Al \| 14.04 \| 986.26%	SLC25A5 \| E1_Da \| 14.31 \| 489.25%
76	COX7C \| E3_Da \| 14.04 \| 644.28%	ACTB \| E4_Af \| 14.04 \| 85.26%	TUBA1B \| E4_Ab \| 14.30 \| 66.73%
77	RPS3A \| E4_Dc \| 14.03 \| 212.68%	CD99 \| E1_Ae \| 14.02 \| 657.08%	RPL4 \| E9_Ab \| 14.28 \| 123.04%
78	SLC25A5 \| E1_Da \| 14.03 \| 522.51%	KIFC1 \| E4_Ab \| 14.01 \| 6297.13%	PABPC1 \| E10_Da \| 14.24 \| 305.63%
79	RPL4 \| E10_Ab \| 14.02 \| 115.89%	NPM1 \| E4_Da \| 13.99 \| 448.73%	ACTB \| E6_Dm \| 14.24 \| 56.21%
80	BTF3 \| E1_Ah \| 14.02 \| 563.91%	COX7C \| E1_Af \| 13.99 \| 880.22%	COMMD1 \| E8_Ac \| 14.21 \| 9255.84%
81	TUBB \| E5_Db \| 14.00 \| 182.52%	RP11-1280I22.1 \| E1_Ag \| 13.96 \| 930.30%	HLA-C \| E1_Ag \| 14.18 \| 640.46%
82	TUT1 \| E12_Da \| 14.00 \| 389.86%	PTMA \| E8_Dc \| 13.95 \| 183.71%	EEF1B2 \| E1_Ak \| 14.17 \| 532.07%
83	PTMA \| E8_Dc \| 13.98 \| 170.89%	RPL29 \| E3_Da \| 13.95 \| 180.22%	ACTB \| E4_Af \| 14.17 \| 53.37%
84	ATP5E \| E1_Ac \| 13.97 \| 1729.50%	ACTB \| E6_Dm \| 13.92 \| 78.28%	RPL29 \| E3_Da \| 14.16 \| 194.70%
85	KIFC1 \| E4_Ab \| 13.97 \| 4233.12%	PABPC1 \| E10_Da \| 13.92 \| 297.25%	COX7C \| E3_Da \| 14.15 \| 729.32%
86	ACTB \| E7_Da \| 13.95 \| 58.64%	LAPTM5 \| E1_Ac \| 13.89 \| 197.80%	HLA-DPA1 \| E3_Da \| 14.12 \| 643.05%
87	TUBB \| E5_Ab \| 13.93 \| 173.67%	TPT1 \| E2_Da \| 13.87 \| 79.65%	RPL35A \| E6_Db \| 14.11 \| 391.63%
88	EEF1A1 \| E4_Ab \| 13.93 \| 269.01%	RPSAP58 \| E6_Ab \| 13.86 \| 3876.28%	TUBB \| E3_Da \| 14.09 \| 122.87%
89	SNRPD3 \| E3_Da \| 13.89 \| 939.73%	PABPC1 \| E1_Ah \| 13.86 \| 284.32%	ACTB \| E6_Dh \| 14.08 \| 50.27%
90	SNX17 \| E1_Ah \| 13.89 \| 1502.05%	TUBA1C \| E5_Ab \| 13.85 \| 1072.92%	RPL34 \| E3_Da \| 14.07 \| 557.18%
91	RPL35A \| E6_Db \| 13.88 \| 323.12%	GNB2L1 \| E8_Df \| 13.83 \| 545.58%	RPS21 \| E3_Df \| 14.07 \| 281.86%
92	GAPDH \| E5_Dh \| 13.88 \| 80.85%	HNRNPD \| E3_Ah \| 13.81 \| 1473.93%	LDHB \| E1_Ad \| 14.06 \| 325.05%
93	HLA-DRA \| E1_Ad \| 13.87 \| 165.65%	SSR4 \| E2_Af \| 13.80 \| 1721.05%	TPT1 \| E2_Da \| 14.04 \| 108.73%
94	ACTB \| E6_Dh \| 13.87 \| 55.70%	HNRNPC \| E2_Da \| 13.79 \| 295.44%	CD53 \| E1_Ad \| 14.04 \| 525.08%
95	HLA-C \| E1_Ag \| 13.84 \| 684.10%	YWHAE \| E1_Ad \| 13.79 \| 478.92%	GNB2L1 \| E8_Df \| 14.03 \| 410.95%
96	AC073621.1 \| E1_Ab \| 13.83 \| 22697.20%	NPIPL3 \| E12_Dd \| 13.79 \| 6966.19%	GNB2L1 \| E5_Ad \| 14.03 \| 410.09%
97	RPL4 \| E4_Da \| 13.83 \| 101.68%	GAPDH \| E5_Dh \| 13.78 \| 61.36%	PTMA \| E8_Dc \| 14.02 \| 191.25%
98	RPS8 \| E4_Da \| 13.83 \| 171.22%	DENND1B \| E4_Da \| 13.78 \| 86780.12%	HLA-B \| E1_Dj \| 13.98 \| 331.97%
99	HNRNPA3 \| E1_Da \| 13.83 \| 1062.65%	RP11-1113N2.2 \| E1_Ac \| 13.75 \| 66131.35%	HLA-DRA \| E5_Ab \| 13.98 \| 51.47%
100	TUBA1B \| E4_Ab \| 13.83 \| 68.19%	TPT1 \| E1_Dd \| 13.74 \| 72.39%	PABPC1 \| E1_Ah \| 13.97 \| 253.35%
101	GNB2L1 \| E9_Ac \| 13.82 \| 408.45%	GAPDH \| E5_Ah \| 13.74 \| 59.41%	RPL32 \| E2_Da \| 13.97 \| 214.01%
102	ACTB \| E4_Af \| 13.80 \| 52.95%	ACTB \| E6_Ah \| 13.72 \| 68.26%	RPLP0 \| E2_Ab \| 13.97 \| 40.06%
103	GNB2L1 \| E8_Df \| 13.80 \| 403.66%	HLA-DQA1 \| E4_Ah \| 13.69 \| 3725.92%	EEF1A1 \| E4_Ab \| 13.97 \| 243.84%
104	RPSAP58 \| E6_Ab \| 13.77 \| 960.03%	EEF1A1 \| E5_Da \| 13.68 \| 250.21%	TUBB \| E5_Ad \| 13.96 \| 112.50%
105	PTMA \| E6_Dc \| 13.76 \| 147.11%	COX7C \| E3_Da \| 13.66 \| 703.44%	HLA-DPA1 \| E2_Ag \| 13.95 \| 569.42%
106	RPL23 \| E6_Db \| 13.75 \| 309.83%	PTMA \| E6_Dc \| 13.63 \| 147.07%	PABPC1 \| E6_Ab \| 13.95 \| 248.65%
107	RPL34 \| E3_Da \| 13.75 \| 407.58%	RPL9 \| E2_Da \| 13.62 \| 326.49%	DENND1B \| E4_Da \| 13.93 \| 82648.33%
108	TUBB \| E3_Da \| 13.73 \| 150.51%	DAZAP2 \| E3_Ab \| 13.62 \| 520.43%	GNB2L1 \| E9_Ac \| 13.92 \| 380.10%
109	HNRNPC \| E2_Da \| 13.72 \| 306.35%	HNRPA1L3 \| E1_Dd \| 13.62 \| 26386.31%	HNRNPC \| E2_Da \| 13.91 \| 290.86%
110	ACTB \| E6_Af \| 13.71 \| 49.91%	TXN \| E1_Ab \| 13.61 \| 457.72%	ACTB \| E7_Db \| 13.91 \| 44.59%
111	SLC25A5 \| E3_Ab \| 13.70 \| 417.16%	MBNL1 \| E3_Af \| 13.60 \| 1528.68%	RPS3A \| E4_Dc \| 13.90 \| 167.58%
112	CASP4 \| E3_Da \| 13.67 \| 1134.12%	PABPC1 \| E6_Ab \| 13.60 \| 237.77%	ACTB \| E6_Af \| 13.89 \| 44.02%
113	RPLP0 \| E2_Ab \| 13.66 \| 33.97%	GNB2L1 \| E9_Ac \| 13.58 \| 461.02%	RPS3A \| E4_Db \| 13.88 \| 165.41%
114	GAPDH \| E5_Ah \| 13.66 \| 69.20%	HNRNPA2B1 \| E3_Ab \| 13.57 \| 578.26%	AC073621.1 \| E1_Ab \| 13.86 \| 28822.69%
115	GNB2L1 \| E5_Da \| 13.65 \| 363.32%	TUBB \| E5_Ab \| 13.57 \| 192.66%	SNX17 \| E1_Ah \| 13.85 \| 1351.72%
116	PCNA \| E2_Ab \| 13.63 \| 299.86%	CD34 \| E3_Ab \| 13.57 \| 302.04%	SLC25A6 \| E1_Ae \| 13.85 \| 351.63%
117	COMMD1 \| E8_Ac \| 13.61 \| 7223.04%	ACTB \| E7_Ab \| 13.56 \| 60.98%	ACTB \| E7_Da \| 13.85 \| 42.75%
118	PABPC1 \| E6_Ab \| 13.59 \| 206.54%	RPL39 \| E3_Da \| 13.56 \| 238.50%	STMN1 \| E7_Db \| 13.84 \| 435.53%
119	HNRNPA2B1 \| E3_Ab \| 13.58 \| 566.67%	TUBB \| E5_Db \| 13.54 \| 188.51%	RPL4 \| E4_Da \| 13.83 \| 90.58%
120	PTMA \| E8_Dg \| 13.58 \| 129.60%	RPL13 \| E1_Df \| 13.53 \| 259.26%	TUBB \| E5_Ac \| 13.82 \| 102.16%
121	EEF1A1 \| E5_Da \| 13.58 \| 210.67%	RPL4 \| E10_Ab \| 13.53 \| 89.83%	TUT1 \| E12_Da \| 13.82 \| 354.09%
122	PTMA \| E8_Dd \| 13.57 \| 129.04%	ENO1 \| E1_Ae \| 13.52 \| 205.41%	RPS20 \| E1_Dh \| 13.82 \| 235.47%
123	GNB2L1 \| E5_Ad \| 13.57 \| 344.25%	NPIPL3 \| E12_Dh \| 13.52 \| 5777.14%	CD74 \| E8_Dc \| 13.79 \| 73.04%
124	HLA-DRA \| E2_Ab \| 13.57 \| 133.92%	HLA-DRA \| E3_Db \| 13.52 \| 88.93%	RPL9 \| E2_Da \| 13.79 \| 247.48%
125	RPL30 \| E8_Da \| 13.56 \| 245.47%	HNRNPA3 \| E1_Da \| 13.51 \| 1035.70%	SLC25A5 \| E3_Ab \| 13.78 \| 338.75%
126	AIF1 \| E3_Ad \| 13.54 \| 403.96%	YWHAE \| E1_Ae \| 13.51 \| 393.70%	TOMM7 \| E1_Ae \| 13.76 \| 1006.11%
127	PABPC1 \| E1_Aj \| 13.53 \| 199.00%	RPS8 \| E4_Da \| 13.50 \| 147.14%	PTMA \| E6_Dc \| 13.74 \| 158.25%
128	RPL39 \| E3_Da \| 13.53 \| 119.60%	RPS3A \| E4_Db \| 13.50 \| 224.71%	CD74 \| E8_Dd \| 13.74 \| 70.45%
129	ACTB \| E7_Db \| 13.53 \| 43.80%	ACTB \| E6_Dh \| 13.50 \| 58.33%	RPS8 \| E4_Da \| 13.74 \| 143.82%
130	GNB2L1 \| E8_Da \| 13.53 \| 333.95%	QARS \| E1_Ai \| 13.50 \| 1290.81%	SNRPD3 \| E3_Da \| 13.72 \| 896.84%
131	NCRNA00188 \| E2_Db \| 13.52 \| 506.67%	AC100786.1 \| E1_Da \| 13.49 \| 34.99%	TUBB \| E5_Da \| 13.71 \| 94.57%
132	AC100778.1 \| E2_Ab \| 13.52 \| 146.44%	IL2RG \| E2_Ah \| 13.46 \| 455.95%	GNB2L1 \| E5_Da \| 13.70 \| 327.65%
133	CD74 \| E8_Db \| 13.49 \| 163.57%	TUBB \| E3_Da \| 13.46 \| 178.33%	TXN \| E1_Ab \| 13.68 \| 461.90%
134	RPL13 \| E1_Df \| 13.49 \| 235.14%	EEF1A1 \| E4_Ab \| 13.46 \| 214.16%	PCNA \| E2_Ab \| 13.68 \| 338.20%
135	SH3BGRL3 \| E2_Db \| 13.48 \| 470.26%	LDHB \| E1_Ad \| 13.45 \| 288.61%	CD74 \| E8_De \| 13.66 \| 66.68%
136	CD53 \| E1_Ad \| 13.47 \| 599.02%	RBM3 \| E1_Ag \| 13.44 \| 711.39%	CASP4 \| E3_Da \| 13.65 \| 1099.79%
137	AC121253.1 \| E1_Da \| 13.45 \| 43751.30%	RPSAP58 \| E6_Da \| 13.44 \| 2909.30%	RPL22 \| E7_Da \| 13.64 \| 669.09%
138	NASP \| E2_Af \| 13.43 \| 1625.69%	GPX1 \| E1_Ac \| 13.44 \| 278.08%	HNRPA1L3 \| E1_Dd \| 13.63 \| 30292.64%
139	YWHAE \| E1_Ad \| 13.42 \| 355.22%	CD74 \| E8_Dd \| 13.39 \| 79.36%	HMGN2 \| E3_Dh \| 13.62 \| 124.71%
140	SLC25A6 \| E1_Ae \| 13.41 \| 304.02%	PGK1 \| E5_Da \| 13.39 \| 792.20%	TPT1 \| E1_Dd \| 13.62 \| 80.76%
141	FTH1 \| E1_Da \| 13.40 \| 118.05%	RBM3 \| E2_Dh \| 13.39 \| 684.86%	PTMA \| E8_Dd \| 13.61 \| 144.59%
142	TPT1 \| E2_Da \| 13.38 \| 102.19%	RPS3A \| E4_Dc \| 13.38 \| 206.48%	YWHAE \| E1_Ad \| 13.61 \| 310.47%
143	TUBB \| E5_Ac \| 13.37 \| 117.50%	GNB2L1 \| E8_Da \| 13.38 \| 399.76%	HIST1H2BK \| E1_Ab \| 13.58 \| 621.74%
144	HNRPA1L3 \| E1_De \| 13.37 \| 23566.12%	HMGB1 \| E5_Ae \| 13.36 \| 408.92%	SH3BGRL \| E1_Ab \| 13.58 \| 357.94%
145	RPL32 \| E3_Da \| 13.36 \| 151.00%	DAZAP2 \| E3_Ac \| 13.35 \| 430.63%	UQCRB \| E1_Di \| 13.56 \| 3414.13%
146	RPL9 \| E2_Da \| 13.35 \| 265.90%	TMSL3 \| E1_Da \| 13.33 \| 4541.42%	RPL30 \| E8_Da \| 13.54 \| 229.29%
147	RPL5 \| E5_Db \| 13.32 \| 265.69%	GNB2L1 \| E5_Da \| 13.33 \| 386.25%	DAZAP2 \| E3_Ac \| 13.54 \| 430.54%
148	RPL22 \| E7_Da \| 13.31 \| 437.97%	ATP5C1 \| E1_Ah \| 13.32 \| 689.77%	RPS8 \| E4_Dc \| 13.53 \| 124.85%
149	GAS5 \| E3_Af \| 13.31 \| 1026.68%	RPL32 \| E3_Da \| 13.32 \| 233.11%	GNB2L1 \| E8_Da \| 13.53 \| 289.67%
150	RPS8 \| E4_Dc \| 13.27 \| 115.70%	CECR1 \| E5_Ad \| 13.31 \| 1414.29%	XPNPEP3 \| E18_Ab \| 13.53 \| 65059.03%
151	TMSL3 \| E1_Da \| 13.25 \| 3990.83%	LAPTM5 \| E8_Db \| 13.31 \| 132.56%	TMSL3 \| E1_Da \| 13.49 \| 3502.55%
152	TUBB \| E5_Ad \| 13.24 \| 107.61%	SH3BGRL \| E1_Ab \| 13.29 \| 413.18%	PTMA \| E8_Dg \| 13.48 \| 131.73%
153	RPS3A \| E3_Dc \| 13.23 \| 122.63%	SNRPD3 \| E1_Ag \| 13.28 \| 602.38%	AC121253.1 \| E1_Da \| 13.47 \| 48309.47%
154	HLA-B \| E1_Dj \| 13.23 \| 327.44%	TUBA1B \| E4_Ab \| 13.27 \| 57.28%	LDHA \| E6_Da \| 13.46 \| 208.92%
155	TUT1 \| E17_Da \| 13.23 \| 227.41%	POLR2J3 \| E4_Aj \| 13.26 \| 10808.30%	RPL5 \| E5_Db \| 13.46 \| 290.38%
156	RPL8 \| E5_Da \| 13.21 \| 105.66%	RPS3A \| E3_Db \| 13.26 \| 189.35%	TUBB \| E4_Da \| 13.46 \| 79.33%
157	MBNL1 \| E3_Af \| 13.20 \| 1204.74%	BTF3 \| E1_Ah \| 13.25 \| 441.63%	NDUFA4 \| E1_Ac \| 13.45 \| 1132.96%
158	GAPDH \| E5_Di \| 13.18 \| 49.71%	PABPC1 \| E1_Aj \| 13.25 \| 186.71%	CD34 \| E3_Ab \| 13.44 \| 307.78%
159	TUBB \| E5_Da \| 13.17 \| 102.07%	HLA-DPA1 \| E2_Ag \| 13.24 \| 683.72%	SHISA5 \| E9_Dc \| 13.44 \| 1400.81%
160	SH3BGRL \| E1_Ab \| 13.17 \| 300.13%	CD74 \| E8_Dc \| 13.23 \| 70.89%	RPSAP58 \| E6_Da \| 13.43 \| 476.21%
161	NDUFA4 \| E1_Ac \| 13.16 \| 1054.39%	ACTB \| E6_Af \| 13.22 \| 48.34%	LAPTM5 \| E1_Ac \| 13.43 \| 137.44%
162	RBM3 \| E1_Ag \| 13.14 \| 556.61%	SFRS3 \| E1_Ac \| 13.22 \| 352.91%	SFRS3 \| E1_Ac \| 13.43 \| 318.13%
163	RPL18AP3 \| E1_Ab \| 13.14 \| 103811.81%	HLA-DRA \| E3_Ab \| 13.21 \| 71.93%	NCRNA00188 \| E1_Al \| 13.42 \| 830.92%
164	SNRPD3 \| E1_Ag \| 13.14 \| 556.47%	AC011247.2 \| E1_Da \| 13.19 \| 15270.91%	EEF1A1 \| E5_Da \| 13.42 \| 167.38%
165	NASP \| E5_Ab \| 13.13 \| 1319.72%	RP11-889L3.1 \| E1_Da \| 13.17 \| 127781.97%	YWHAE \| E1_Ae \| 13.39 \| 266.07%
166	RPS4X \| E6_Dc \| 13.13 \| 67.91%	SHISA5 \| E9_Dc \| 13.16 \| 1120.92%	STMN1 \| E7_Dd \| 13.38 \| 317.62%
167	HMGN2 \| E3_Dh \| 13.12 \| 115.16%	TMED9 \| E1_Ac \| 13.15 \| 638.07%	LGALS1 \| E6_Da \| 13.37 \| 498.96%
168	SHISA5 \| E9_Dc \| 13.12 \| 1338.93%	HLA-B \| E1_Dj \| 13.13 \| 294.47%	GNAS \| E21_Dd \| 13.37 \| 1006.34%
169	RP11-889L3.1 \| E1_Da \| 13.11 \| 83637.16%	TIMP1 \| E4_Db \| 13.12 \| 569.38%	EEF1A1 \| E6_Ab \| 13.36 \| 159.96%
170	TPT1 \| E1_Dd \| 13.11 \| 84.41%	GNB2L1 \| E3_Ap \| 13.12 \| 334.55%	RPL18AP3 \| E1_Ab \| 13.35 \| 130696.09%
171	ENSA \| E5_Da \| 13.09 \| 963.87%	HLA-DQB1 \| E3_Ab \| 13.12 \| 3514.91%	GPX1 \| E1_Ac \| 13.35 \| 224.69%
172	CD74 \| E1_Ag \| 13.09 \| 123.47%	ACTB \| E7_Da \| 13.10 \| 44.39%	PHB \| E3_Ab \| 13.34 \| 1188.75%
173	EIF3E \| E5_Ah \| 13.08 \| 1145.02%	GNAS \| E20_Di \| 13.09 \| 734.83%	AC100778.1 \| E2_Ab \| 13.33 \| 157.24%
174	RPS24 \| E3_Db \| 13.08 \| 160.81%	GNAI2 \| E13_Db \| 13.08 \| 936.97%	RPL13 \| E1_Df \| 13.33 \| 202.57%
175	PABPC1 \| E12_Ac \| 13.08 \| 145.50%	HNRNPK \| E1_Ae \| 13.08 \| 317.81%	UBE2C \| E1_Af \| 13.29 \| 410.02%
176	AC011247.2 \| E1_Da \| 13.08 \| 26183.66%	LDHA \| E6_Da \| 13.08 \| 233.46%	HNRNPA2B1 \| E3_Ab \| 13.28 \| 562.98%
177	NCL \| E8_Da \| 13.06 \| 404.82%	RPL35A \| E6_Db \| 13.07 \| 246.48%	TUT1 \| E17_Da \| 13.28 \| 242.99%
178	ENO1 \| E1_Ae \| 13.05 \| 176.78%	FXYD5 \| E1_Ae \| 13.06 \| 308.90%	HLA-DPB1 \| E1_Ad \| 13.27 \| 249.17%
179	GNB2L1 \| E5_Ac \| 13.05 \| 240.77%	FAIM3 \| E2_Ac \| 13.06 \| 1037.19%	TUBA1B \| E4_Da \| 13.25 \| 32.33%
180	RBM3 \| E2_Dh \| 13.05 \| 521.55%	RPL18AP3 \| E1_Ab \| 13.06 \| 50388.63%	RPL39 \| E3_Da \| 13.24 \| 81.82%
181	SFRS3 \| E1_Ac \| 13.05 \| 264.50%	PABPC1 \| E12_Ac \| 13.05 \| 162.79%	RP11-889L3.1 \| E1_Da \| 13.23 \| 87797.80%
182	YWHAE \| E1_Ae \| 13.04 \| 273.65%	NONO \| E1_Ag \| 13.05 \| 340.43%	HNRNPA3 \| E1_Da \| 13.22 \| 797.59%
183	GNAS \| E21_Dd \| 13.04 \| 806.14%	PTMA \| E8_Db \| 13.04 \| 97.57%	HLA-DQB1 \| E3_Ab \| 13.21 \| 3661.65%
184	UROD \| E2_Ag \| 13.04 \| 799.94%	TUBB \| E5_Ac \| 13.03 \| 132.51%	NONO \| E7_Da \| 13.21 \| 353.78%
185	HNRNPD \| E3_Ah \| 13.03 \| 919.94%	AIF1 \| E3_Ad \| 13.02 \| 392.42%	DNAJB6 \| E7_Db \| 13.21 \| 3738.80%
186	DAZAP2 \| E3_Ac \| 13.02 \| 402.41%	CCNI \| E9_Da \| 13.02 \| 479.11%	HNRPA1L3 \| E1_De \| 13.20 \| 22500.52%
187	PTMA \| E8_Db \| 13.01 \| 87.11%	CD74 \| E8_De \| 13.02 \| 61.36%	GNB2L1 \| E5_Ac \| 13.20 \| 230.54%
188	RPSAP58 \| E6_Da \| 13.00 \| 561.19%	FTH1 \| E1_Da \| 13.01 \| 140.67%	DAZAP2 \| E3_Ab \| 13.20 \| 339.76%
189	YBX1 \| E5_Da \| 12.99 \| 187.85%	AC106788.2 \| E8_Ac \| 13.00 \| 1900.49%	FNTB \| E1_Ac \| 13.19 \| 2140.77%
190	LAPTM5 \| E1_Ac \| 12.98 \| 182.71%	HLA-DPB1 \| E1_Ad \| 12.99 \| 325.29%	SNRPD3 \| E1_Ag \| 13.18 \| 620.37%
191	NONO \| E7_Da \| 12.97 \| 326.46%	RPS23 \| E3_Ac \| 12.99 \| 477.96%	SPCS1 \| E2_Ad \| 13.18 \| 647.59%
192	HNRNPAB \| E7_Db \| 12.97 \| 455.32%	RPL30 \| E8_Da \| 12.99 \| 168.99%	GNAI2 \| E13_Db \| 13.18 \| 762.90%
193	PABPC1 \| E9_Ac \| 12.97 \| 134.39%	GPX1 \| E1_Db \| 12.97 \| 200.40%	CHCHD2 \| E1_Ab \| 13.18 \| 281.37%
194	GAS5 \| E5_De \| 12.96 \| 808.30%	ENSA \| E5_Da \| 12.97 \| 966.65%	YBX1 \| E5_Da \| 13.18 \| 195.94%
195	NPIPL3 \| E12_Dd \| 12.95 \| 6234.79%	PCNA \| E2_Ab \| 12.97 \| 331.06%	HLA-B \| E2_Da \| 13.16 \| 188.27%
196	HNRNPK \| E17_Dd \| 12.94 \| 285.71%	RPL8 \| E5_Da \| 12.95 \| 90.16%	RPS4X \| E6_Dc \| 13.16 \| 65.36%
197	UBE2C \| E1_Af \| 12.94 \| 380.84%	AC121253.1 \| E1_Da \| 12.95 \| 83229.26%	LAPTM5 \| E8_Db \| 13.15 \| 113.34%
198	RPL5 \| E8_Da \| 12.92 \| 201.02%	HLA-DPA1 \| E3_Da \| 12.94 \| 555.65%	RPS3A \| E3_Dc \| 13.14 \| 98.92%
199	PABPC1 \| E7_Ac \| 12.91 \| 128.74%	COX7A2L \| E2_Af \| 12.93 \| 1413.61%	TPM3 \| E7_Aj \| 13.13 \| 754.97%
200	HMGB1 \| E5_Dd \| 12.90 \| 208.59%	NONO \| E7_Da \| 12.92 \| 313.07%	ENO1 \| E1_Ae \| 13.12 \| 115.33%
201	NONO \| E1_Ag \| 12.90 \| 309.79%	SPCS1 \| E2_Ad \| 12.92 \| 619.38%	ENO1 \| E10_Da \| 13.11 \| 114.41%
202	GNB2L1 \| E8_Dl \| 12.90 \| 216.08%	GNB2L1 \| E8_Dl \| 12.92 \| 290.82%	RPL32 \| E3_Da \| 13.10 \| 116.89%
203	RPL10A \| E3_Da \| 12.88 \| 88.05%	GAS5 \| E3_Af \| 12.91 \| 995.73%	KIFC1 \| E4_Ab \| 13.10 \| 2143.97%
204	RPS23 \| E3_Ac \| 12.88 \| 317.84%	TUBB \| E5_Da \| 12.89 \| 120.21%	RPL8 \| E5_Da \| 13.10 \| 111.81%
205	EEF1A1 \| E4_Df \| 12.87 \| 128.47%	HBB \| E4_Da \| 12.88 \| 126.36%	ANP32A \| E6_Ab \| 13.09 \| 1013.69%
206	XPNPEP3 \| E18_Ab \| 12.86 \| 20199.10%	GNAS \| E18_Da \| 12.88 \| 634.04%	EIF3E \| E5_Ah \| 13.08 \| 1140.70%
207	NONO \| E17_Ab \| 12.85 \| 300.10%	IL2RG \| E2_Ai \| 12.87 \| 302.42%	RAN \| E6_Db \| 13.08 \| 304.57%
208	EEF1A1 \| E6_Ab \| 12.85 \| 127.23%	GNAS \| E22_Da \| 12.87 \| 629.09%	GNB2L1 \| E8_Dl \| 13.06 \| 209.77%
209	STMN1 \| E7_Db \| 12.85 \| 357.82%	HNRNPH1 \| E3_De \| 12.85 \| 668.02%	TUBA1C \| E5_Da \| 13.06 \| 414.27%
210	UQCRB \| E1_Aj \| 12.84 \| 2115.85%	FKBP1A \| E1_Ad \| 12.82 \| 224.82%	UQCRB \| E1_Aj \| 13.04 \| 2379.17%
211	DAZAP2 \| E3_Ab \| 12.83 \| 353.91%	GNAS \| E11_Ag \| 12.82 \| 606.48%	PABPC1 \| E12_Ac \| 13.03 \| 132.16%
212	HNRNPK \| E1_Ae \| 12.83 \| 263.54%	RPS3A \| E3_Dc \| 12.81 \| 139.28%	NCRNA00188 \| E2_Db \| 13.02 \| 629.70%
213	AC073621.1 \| E1_Db \| 12.82 \| 11233.80%	AC073621.1 \| E1_Db \| 12.81 \| 16204.50%	PABPC1 \| E9_Ac \| 13.02 \| 131.04%
214	RPS24 \| E4_Da \| 12.80 \| 132.07%	TUT1 \| E12_Db \| 12.78 \| 163.56%	GAPDH \| E6_Da \| 13.02 \| 26.78%
215	QARS \| E1_Ai \| 12.80 \| 1051.38%	RPL10A \| E3_Da \| 12.78 \| 75.24%	GPX1 \| E1_Db \| 13.02 \| 178.27%
216	TUBA1C \| E5_Da \| 12.79 \| 319.12%	TUT1 \| E17_Da \| 12.77 \| 163.01%	PABPC1 \| E7_Ac \| 13.01 \| 130.31%
217	SFPQ \| E7_Ab \| 12.79 \| 648.60%	PABPC1 \| E7_Ac \| 12.77 \| 133.95%	HSPA8 \| E9_Da \| 12.99 \| 78.19%
218	PHB \| E3_Ab \| 12.78 \| 1134.28%	IFITM3 \| E1_Ad \| 12.76 \| 132.27%	HLA-DPA1 \| E2_Da \| 12.98 \| 291.74%
219	PABPC1 \| E3_Ab \| 12.78 \| 117.73%	CD68 \| E2_Da \| 12.75 \| 434.64%	RBM3 \| E2_Dh \| 12.97 \| 590.63%
220	CHCHD2 \| E1_Ab \| 12.77 \| 271.15%	GNAS \| E20_Db \| 12.75 \| 578.76%	AC011247.2 \| E1_Da \| 12.97 \| 28738.14%
221	NPIPL3 \| E12_Dh \| 12.77 \| 5500.02%	HNRNPK \| E17_Dd \| 12.74 \| 251.54%	AIF1 \| E3_Ad \| 12.97 \| 424.02%
222	TUBA1B \| E4_Da \| 12.76 \| 32.56%	RPS24 \| E4_Da \| 12.74 \| 302.23%	NONO \| E17_Ab \| 12.96 \| 296.58%
223	GNAS \| E22_Da \| 12.76 \| 661.34%	NASP \| E2_Af \| 12.73 \| 1538.82%	PTMA \| E8_Db \| 12.96 \| 91.59%
224	PTMA \| E6_Ac \| 12.75 \| 72.89%	HNRPA1L3 \| E1_De \| 12.73 \| 14287.49%	GAPDH \| E6_Db \| 12.95 \| 25.50%
225	DNAJB6 \| E7_Db \| 12.73 \| 3151.91%	NONO \| E17_Ab \| 12.73 \| 272.91%	RAB7A \| E6_Db \| 12.94 \| 348.92%
226	ANP32A \| E6_Ab \| 12.73 \| 968.28%	PHB \| E3_Ab \| 12.73 \| 1181.45%	CCNI \| E9_Da \| 12.94 \| 329.21%
227	RPL5 \| E5_Da \| 12.73 \| 176.92%	PTMA \| E6_Ac \| 12.73 \| 78.35%	HMGB1 \| E5_Dd \| 12.93 \| 220.33%
228	ATPIF1 \| E1_Ad \| 12.73 \| 798.51%	RPS8 \| E4_Dc \| 12.72 \| 85.55%	HNRNPAB \| E7_Db \| 12.93 \| 438.36%
229	SHISA5 \| E8_Ad \| 12.71 \| 1007.57%	EIF3H \| E4_Ag \| 12.70 \| 1197.07%	HLA-DMA \| E4_Ad \| 12.93 \| 370.56%
230	RBMX \| E3_Ab \| 12.71 \| 371.49%	KLF6 \| E4_Db \| 12.68 \| 261.32%	PABPC1 \| E3_Ab \| 12.92 \| 122.42%
231	LDHA \| E6_Da \| 12.71 \| 238.32%	CHCHD2 \| E1_Ab \| 12.68 \| 244.62%	FAIM3 \| E2_Ac \| 12.92 \| 871.81%
232	HLA-DRA \| E3_Db \| 12.70 \| 73.37%	GDI2 \| E3_Ad \| 12.68 \| 391.63%	RP4-756H11.2 \| E1_Da \| 12.92 \| 14137.20%
233	RAN \| E6_Db \| 12.69 \| 228.83%	YBX1 \| E5_Da \| 12.68 \| 172.74%	ATPIF1 \| E1_Ad \| 12.92 \| 900.73%
234	RPS3A \| E4_Da \| 12.69 \| 83.84%	PARVG \| E4_Af \| 12.67 \| 792.30%	ENSA \| E5_Da \| 12.92 \| 913.60%
235	TPM3 \| E7_Aj \| 12.68 \| 850.36%	TUBB \| E5_Ad \| 12.67 \| 103.08%	LIMK2 \| E17_Da \| 12.91 \| 16983.46%
236	TUT1 \| E12_Db \| 12.68 \| 155.27%	NCRNA00188 \| E2_Db \| 12.66 \| 379.17%	RPL10A \| E3_Da \| 12.91 \| 127.69%
237	PABPC1 \| E9_Ad \| 12.67 \| 109.48%	CTD-2192J16.15 \| E1_Ab \| 12.66 \| 19991.50%	PABPC1 \| E1_Aj \| 12.91 \| 121.24%
238	GNAS \| E20_Di \| 12.65 \| 616.29%	HLA-DRA \| E5_Ab \| 12.66 \| 49.13%	GNAS \| E20_Di \| 12.91 \| 732.24%
239	GNAI2 \| E13_Db \| 12.64 \| 836.81%	LGALS9 \| E3_Ab \| 12.65 \| 877.72%	RBM3 \| E1_Ag \| 12.91 \| 565.33%
240	CTD-2192J16.15 \| E1_Ab \| 12.61 \| 30635.70%	CD52 \| E3_Da \| 12.65 \| 302.97%	CNBP \| E2_De \| 12.90 \| 444.95%
241	STMN1 \| E7_Dd \| 12.60 \| 302.42%	ACTB \| E7_Db \| 12.65 \| 32.46%	GNAS \| E22_Da \| 12.90 \| 726.37%
242	GNAS \| E18_Da \| 12.60 \| 593.32%	SFPQ \| E7_Ab \| 12.65 \| 651.90%	HNRNPK \| E17_Dd \| 12.89 \| 258.56%
243	HNRNPA3 \| E3_Da \| 12.60 \| 452.64%	ATP6V1F \| E1_Ab \| 12.64 \| 251.84%	LST1 \| E4_Dl \| 12.89 \| 769.92%
244	UQCRB \| E1_Di \| 12.59 \| 1789.17%	SH2D3C \| E1_Ac \| 12.63 \| 946.17%	RHOA \| E10_Db \| 12.88 \| 135.81%
245	POLR2J3 \| E4_Aj \| 12.59 \| 9543.41%	IFITM2 \| E1_Ab \| 12.63 \| 155.19%	HLA-C \| E3_Ac \| 12.87 \| 257.75%
246	HLA-DRA \| E3_Ab \| 12.59 \| 67.92%	LIMK2 \| E17_Da \| 12.63 \| 7433.24%	HNRNPK \| E1_Ae \| 12.87 \| 253.85%
247	HSP90AB1 \| E13_Ab \| 12.56 \| 53.76%	COMMD1 \| E8_Ac \| 12.62 \| 3442.76%	TPM3 \| E11_Dc \| 12.86 \| 626.85%
248	HSPA8 \| E9_Da \| 12.56 \| 66.78%	RPS24 \| E3_Db \| 12.61 \| 276.00%	CD99 \| E15_Db \| 12.81 \| 160.11%
249	PTTG1 \| E2_Ae \| 12.53 \| 814.44%	TMSB4X \| E2_Da \| 12.60 \| 33.51%	NCL \| E8_Da \| 12.81 \| 451.32%
250	ATP6V1F \| E1_Ab \| 12.53 \| 240.52%	COX7A2L \| E2_Ae \| 12.60 \| 1123.44%	TMSB4X \| E2_Da \| 12.81 \| 23.55%
251	PABPC1 \| E2_Dd \| 12.53 \| 99.34%	RPL22 \| E7_Da \| 12.60 \| 358.84%	ATP5C1 \| E1_Ah \| 12.80 \| 496.39%
252	RPS15AP1 \| E1_Ab \| 12.53 \| 102225.57%	PABPC1 \| E9_Ad \| 12.59 \| 118.51%	PTTG1 \| E2_Ae \| 12.80 \| 764.44%
253	GNB2L1 \| E5_Ag \| 12.53 \| 167.28%	AC121253.1 \| E1_Ab \| 12.59 \| 65069.58%	POLR2J3 \| E4_Aj \| 12.79 \| 15126.53%
254	AC121253.1 \| E1_Ab \| 12.51 \| 22790.82%	HLA-A \| E4_Ad \| 12.59 \| 174.17%	HLA-B \| E1_Db \| 12.79 \| 145.10%
255	PABPC1P1 \| E2_Db \| 12.51 \| 41211.88%	HLA-E \| E1_Ae \| 12.58 \| 239.05%	ID3 \| E1_Ab \| 12.78 \| 933.21%
256	GNB2L1 \| E8_Dk \| 12.51 \| 165.09%	RPL34 \| E3_Da \| 12.57 \| 267.58%	HSPA8 \| E7_Da \| 12.78 \| 67.56%
257	TUT1 \| E17_Ab \| 12.51 \| 137.92%	GAS5 \| E5_De \| 12.57 \| 784.26%	GNB2L1 \| E8_Dk \| 12.77 \| 171.06%
258	RPL5 \| E5_Ab \| 12.50 \| 150.99%	RHOA \| E3_Af \| 12.56 \| 164.08%	RPS23 \| E3_Ac \| 12.77 \| 371.16%
259	GLUL \| E1_Ag \| 12.50 \| 651.71%	PPIH \| E1_Ac \| 12.56 \| 363.45%	TPM3 \| E16_Db \| 12.77 \| 586.11%
260	TMSB4X \| E2_Da \| 12.49 \| 30.35%	IFITM3 \| E1_Ab \| 12.55 \| 114.76%	SRP9 \| E1_Ad \| 12.76 \| 166.89%
261	HLA-DPA1 \| E2_Ag \| 12.49 \| 576.78%	PABPC1 \| E3_Ab \| 12.54 \| 114.51%	TCEB2 \| E5_Da \| 12.76 \| 164.31%
262	SPCS1 \| E2_Ad \| 12.48 \| 619.94%	KLF6 \| E1_Ad \| 12.54 \| 236.74%	PABPC1 \| E9_Ad \| 12.76 \| 108.86%
263	RPL18AP3 \| E1_Da \| 12.48 \| 65673.74%	GAPDH \| E5_Di \| 12.54 \| 25.89%	HLA-DPA1 \| E3_Dc \| 12.75 \| 247.25%
264	PTMA \| E3_Af \| 12.47 \| 60.13%	GNB2L1 \| E5_Ag \| 12.53 \| 222.74%	RHOA \| E3_Af \| 12.74 \| 123.72%
265	FNTB \| E1_Ac \| 12.47 \| 1609.78%	RPL13A \| E3_Db \| 12.53 \| 20.31%	RPL5 \| E8_Da \| 12.74 \| 176.20%
266	HLA-DRA \| E5_Ab \| 12.46 \| 62.25%	ATPIF1 \| E1_Ad \| 12.53 \| 803.42%	AC073621.1 \| E1_Db \| 12.74 \| 13278.46%
267	SSR4 \| E2_Af \| 12.45 \| 1590.56%	IER2 \| E2_Ab \| 12.53 \| 334.60%	COX7A2L \| E7_Da \| 12.74 \| 1249.76%
268	TUBB \| E4_Da \| 12.45 \| 62.10%	GNB2L1 \| E3_Aq \| 12.52 \| 221.22%	COX7A2L \| E2_Ae \| 12.74 \| 1249.02%
269	RAB7A \| E6_Db \| 12.45 \| 353.73%	EIF3H \| E7_Da \| 12.52 \| 1060.49%	MBNL1 \| E3_Af \| 12.73 \| 1014.12%
270	PGK1 \| E5_Da \| 12.44 \| 512.46%	ARPC5 \| E1_Ac \| 12.51 \| 759.46%	RBMX \| E3_Ab \| 12.73 \| 369.49%
271	HLA-DQA1 \| E4_Ah \| 12.43 \| 3331.82%	UROD \| E2_Ag \| 12.51 \| 793.03%	GNAS \| E18_Da \| 12.72 \| 644.22%
272	LST1 \| E4_Dl \| 12.43 \| 865.10%	CD44 \| E5_Da \| 12.51 \| 430.61%	NASP \| E2_Af \| 12.72 \| 1450.68%
273	RHOA \| E3_Af \| 12.42 \| 146.39%	HLA-DPA1 \| E2_Da \| 12.51 \| 411.97%	QARS \| E1_Ai \| 12.72 \| 983.46%
274	CNBP \| E2_De \| 12.42 \| 388.27%	CPSF3L \| E4_Dc \| 12.51 \| 2579.51%	HLA-B \| E1_Di \| 12.72 \| 138.47%
275	RPS6 \| E4_Da \| 12.41 \| 51.54%	RPL5 \| E5_Db \| 12.50 \| 221.04%	RPS14 \| E1_Ah \| 12.70 \| 253.24%
276	SF1 \| E1_Ah \| 12.40 \| 592.51%	GNAS \| E21_Dd \| 12.50 \| 487.78%	EIF1 \| E1_Ae \| 12.70 \| 396.29%
277	HNRNPD \| E7_Da \| 12.40 \| 595.74%	HNRNPD \| E3_Ae \| 12.50 \| 597.23%	TIMM8B \| E1_Ac \| 12.69 \| 412.18%
278	GAPDH \| E6_Db \| 12.40 \| 28.89%	TPM3 \| E16_Db \| 12.50 \| 781.27%	TPM4 \| E4_Da \| 12.68 \| 126.57%
279	HBB \| E5_Da \| 12.40 \| 37.47%	PABPC1 \| E9_Ac \| 12.49 \| 110.08%	EEF1A1 \| E4_Df \| 12.68 \| 99.69%
280	RPL21 \| E6_Da \| 12.39 \| 63.86%	PABPC1P1 \| E2_Db \| 12.48 \| 21670.83%	RPL5 \| E5_Da \| 12.66 \| 166.98%
281	COX7A2L \| E2_Af \| 12.38 \| 1340.16%	ATP5O \| E1_Ad \| 12.48 \| 792.91%	SSR4 \| E2_Af \| 12.66 \| 1906.27%
282	HDGF \| E10_Dh \| 12.38 \| 380.88%	CCT8 \| E1_Ad \| 12.47 \| 524.58%	HMGN2 \| E3_Dc \| 12.65 \| 63.71%
283	RBM3 \| E4_Dd \| 12.37 \| 327.18%	HNRNPA3 \| E3_Da \| 12.47 \| 503.26%	COX7A2L \| E2_Af \| 12.64 \| 1171.75%
284	ENO1 \| E10_Da \| 12.37 \| 110.26%	BST2 \| E1_Ac \| 12.47 \| 249.91%	PABPC1P1 \| E2_Db \| 12.63 \| 48362.51%
285	CCNI \| E9_Da \| 12.36 \| 295.68%	P4HB \| E7_Ab \| 12.47 \| 215.45%	SELL \| E3_Ab \| 12.63 \| 49.02%
286	GPX1 \| E1_Ac \| 12.36 \| 218.96%	HLA-DMA \| E4_Ad \| 12.45 \| 369.57%	PTMA \| E3_Af \| 12.63 \| 72.87%
287	RPS15AP1 \| E1_Da \| 12.36 \| 90831.57%	SRP9 \| E1_Ad \| 12.45 \| 282.18%	RPS24 \| E3_Db \| 12.61 \| 110.75%
288	EIF1 \| E1_Ae \| 12.35 \| 302.81%	RPL10 \| E6_Dg \| 12.45 \| 68.04%	H3F3A \| E5_Da \| 12.61 \| 142.76%
289	HLA-B \| E2_Da \| 12.35 \| 177.85%	RBMX \| E3_Ab \| 12.45 \| 361.31%	PGK1 \| E5_Da \| 12.61 \| 477.42%
290	HLA-DPA1 \| E3_Da \| 12.35 \| 522.03%	GNB2L1 \| E5_Ac \| 12.45 \| 210.37%	RTN4 \| E18_Dd \| 12.58 \| 1379.28%
291	AC073621.1 \| E1_Da \| 12.34 \| 8070.39%	SNRPB \| E1_Ac \| 12.45 \| 420.90%	GDI2 \| E3_Ad \| 12.57 \| 319.91%
292	CD74 \| E8_Dd \| 12.34 \| 73.53%	AP2M1 \| E1_Af \| 12.45 \| 521.62%	ATP6V1F \| E1_Ab \| 12.56 \| 258.94%
293	AC092798.2 \| E1_Ab \| 12.33 \| 39601.29%	ENSA \| E1_Da \| 12.45 \| 674.72%	CD99 \| E1_Ad \| 12.55 \| 133.70%
294	GAPDH \| E6_Da \| 12.33 \| 27.61%	RPL5 \| E5_Da \| 12.45 \| 212.40%	GNB2L1 \| E5_Ag \| 12.55 \| 147.49%
295	PPIH \| E1_Ac \| 12.33 \| 333.40%	EEF1A1 \| E6_Ab \| 12.44 \| 105.77%	GNB2L1 \| E5_Db \| 12.55 \| 146.88%
296	GNB2L1 \| E5_Db \| 12.33 \| 145.65%	RPL18AP3 \| E1_Da \| 12.44 \| 32712.21%	HNRNPD \| E3_Ah \| 12.54 \| 742.55%
297	GNB2L1 \| E3_Aq \| 12.32 \| 145.25%	ANP32A \| E6_Ab \| 12.44 \| 764.56%	NDUFA13 \| E1_Ai \| 12.54 \| 1152.24%
298	HMGN2 \| E3_Dc \| 12.32 \| 66.20%	EIF3D \| E4_Da \| 12.43 \| 584.21%	NONO \| E1_Ag \| 12.53 \| 220.78%
299	LAPTM5 \| E8_Db \| 12.32 \| 115.29%	EIF1 \| E1_Ae \| 12.43 \| 294.25%	SERF2 \| E4_Ae \| 12.52 \| 382.22%
300	PABPC1 \| E2_Dc \| 12.31 \| 85.12%	NASP \| E5_Ab \| 12.43 \| 1244.32%	PABPC1 \| E2_Dc \| 12.52 \| 92.52%
301	TPM3 \| E16_Db \| 12.31 \| 657.09%	RPS15AP1 \| E1_Da \| 12.41 \| 48257.78%	LAPTM5 \| E8_Ab \| 12.52 \| 73.17%
302	NCL \| E8_Ac \| 12.31 \| 240.87%	TMEM66 \| E5_Ac \| 12.40 \| 322.33%	HLA-A \| E4_Ad \| 12.51 \| 137.45%
303	ATP5C1 \| E1_Ah \| 12.30 \| 413.99%	ENO1 \| E10_Da \| 12.40 \| 94.14%	HMGN2 \| E3_Dd \| 12.51 \| 57.93%
304	RPL5 \| E1_Ae \| 12.30 \| 130.88%	CANX \| E8_Db \| 12.39 \| 261.88%	HDGF \| E10_Dh \| 12.50 \| 413.18%
305	ZNF90 \| E18_Da \| 12.28 \| 8490.61%	WIPF1 \| E11_Ad \| 12.39 \| 795.12%	HLA-DPA1 \| E3_Ad \| 12.49 \| 207.45%
306	MCM4 \| E16_Da \| 12.28 \| 590.23%	RAB7A \| E6_Db \| 12.39 \| 287.27%	LAIR1 \| E5_Da \| 12.49 \| 700.53%
307	MCL1 \| E1_Ab \| 12.28 \| 291.73%	HSP90AB1 \| E13_Ab \| 12.38 \| 49.23%	RPL15 \| E1_Dk \| 12.49 \| 169.56%
308	TAGLN2 \| E7_Db \| 12.28 \| 152.27%	AC073621.1 \| E1_Da \| 12.37 \| 11925.76%	RPL5 \| E1_Ae \| 12.48 \| 147.66%
309	ENSA \| E1_Da \| 12.27 \| 543.48%	GNB2L1 \| E5_Db \| 12.36 \| 198.21%	NASP \| E5_Ab \| 12.48 \| 1221.82%
310	PABPC1 \| E14_Db \| 12.27 \| 82.65%	TUT1 \| E17_Ab \| 12.36 \| 122.11%	RPL13A \| E2_Df \| 12.48 \| 23.21%
311	GPX1 \| E1_Db \| 12.26 \| 203.19%	CD68 \| E1_Ab \| 12.35 \| 329.12%	ENSA \| E1_Da \| 12.47 \| 671.76%
312	RPL15 \| E1_Dk \| 12.25 \| 143.96%	UQCRC1 \| E2_Da \| 12.35 \| 799.68%	PABPC1 \| E2_Dd \| 12.46 \| 88.87%
313	RBM3 \| E2_Db \| 12.25 \| 299.87%	PABPC1 \| E2_Dd \| 12.35 \| 100.34%	UQCR10 \| E1_Da \| 12.46 \| 325.57%
314	ERGIC3 \| E15_Dd \| 12.24 \| 1300.82%	HNRNPH1 \| E7_Ad \| 12.35 \| 472.44%	MSN \| E14_Db \| 12.46 \| 92.68%
315	COX5B \| E1_Ab \| 12.24 \| 498.28%	HNRNPH1 \| E5_Af \| 12.35 \| 472.32%	CD99 \| E11_Ab \| 12.45 \| 124.02%
316	GNAS \| E20_Db \| 12.23 \| 460.60%	EIF3E \| E5_Ah \| 12.34 \| 931.48%	RPS3A \| E4_Da \| 12.44 \| 61.25%
317	NPM1 \| E4_Dc \| 12.23 \| 99.38%	CANX \| E11_Ac \| 12.34 \| 253.76%	GNB2L1 \| E9_De \| 12.43 \| 135.68%
318	EIF3H \| E4_Ag \| 12.21 \| 826.86%	NDUFA13 \| E1_Ai \| 12.34 \| 1130.74%	SELL \| E10_Da \| 12.41 \| 42.13%
319	GNAS \| E11_Ag \| 12.20 \| 451.37%	GNB2L1 \| E5_Ad \| 12.33 \| 192.94%	RALY \| E1_Ae \| 12.41 \| 552.20%
320	CD74 \| E8_De \| 12.20 \| 67.03%	XPNPEP3 \| E18_Ab \| 12.31 \| 12420.78%	APEX1 \| E5_Da \| 12.40 \| 107.22%
321	RHOA \| E10_Db \| 12.20 \| 125.61%	GNB2L1 \| E8_Dk \| 12.31 \| 190.82%	GNAS \| E20_Db \| 12.40 \| 513.05%
322	GDI2 \| E3_Ad \| 12.20 \| 360.44%	CANX \| E17_Db \| 12.31 \| 247.94%	HMGN2 \| E3_Dg \| 12.39 \| 53.33%
323	METTL7A \| E1_Da \| 12.20 \| 493.95%	HMGN2 \| E3_Dh \| 12.30 \| 108.39%	TUT1 \| E17_Ab \| 12.39 \| 131.52%
324	TIMP1 \| E4_Db \| 12.19 \| 535.22%	SHISA5 \| E8_Ad \| 12.29 \| 614.48%	IL2RG \| E2_Ah \| 12.39 \| 222.65%
325	HMGB1 \| E7_Db \| 12.19 \| 127.56%	RPL5 \| E5_Ab \| 12.29 \| 191.12%	SHISA5 \| E8_Ad \| 12.39 \| 677.15%
326	HSP90AA1 \| E5_Da \| 12.19 \| 123.93%	EEF1A1 \| E4_Df \| 12.29 \| 95.33%	PPIH \| E1_Ac \| 12.39 \| 366.29%
327	COX7A2L \| E7_Da \| 12.18 \| 1168.86%	GAPDH \| E6_Da \| 12.29 \| 21.80%	HNRNPA3 \| E3_Da \| 12.39 \| 447.24%
328	RPL10 \| E6_Dg \| 12.18 \| 80.73%	GLUL \| E1_Ag \| 12.29 \| 600.49%	TIMP1 \| E4_Db \| 12.39 \| 542.95%
329	PTMA \| E8_De \| 12.18 \| 49.14%	RPS3A \| E4_Da \| 12.29 \| 96.66%	SFPQ \| E7_Ab \| 12.38 \| 699.87%
330	IER2 \| E2_Ab \| 12.18 \| 372.36%	HLA-B \| E1_Di \| 12.28 \| 163.63%	CD99 \| E15_Da \| 12.37 \| 117.98%
331	UQCR10 \| E1_Da \| 12.18 \| 315.85%	SERF2 \| E4_Ae \| 12.28 \| 227.09%	PABPC1 \| E14_Db \| 12.37 \| 83.53%
332	YBX1 \| E5_Ac \| 12.17 \| 106.80%	COX7A2L \| E7_Da \| 12.27 \| 895.68%	LAPTM5 \| E8_Dc \| 12.37 \| 66.09%
333	CD74 \| E8_Dc \| 12.17 \| 65.31%	PTMA \| E3_Af \| 12.27 \| 57.01%	RPL5 \| E5_Ab \| 12.37 \| 136.73%
334	HMGB2 \| E3_Db \| 12.17 \| 183.75%	HNRNPH1 \| E8_Ac \| 12.26 \| 442.61%	RPS15AP1 \| E1_Ac \| 12.37 \| 101030.46%
335	ATP5O \| E1_Ad \| 12.15 \| 702.31%	CUTA \| E1_Ap \| 12.26 \| 464.25%	STX7 \| E4_Da \| 12.37 \| 996.43%
336	LMNB1 \| E1_Ae \| 12.15 \| 641.18%	PSME1 \| E1_Ac \| 12.26 \| 194.38%	TPI1 \| E7_Da \| 12.36 \| 213.46%
337	RPL23 \| E7_Da \| 12.15 \| 101.89%	MAN2B1 \| E1_Ad \| 12.25 \| 537.79%	ATP5O \| E1_Ad \| 12.36 \| 755.53%
338	AC106788.2 \| E8_Ac \| 12.14 \| 1749.93%	RAN \| E6_Db \| 12.25 \| 188.68%	RPS15AP1 \| E1_Da \| 12.36 \| 100408.73%
339	RPS3A \| E5_Db \| 12.14 \| 57.54%	HNRNPH1 \| E8_Af \| 12.25 \| 439.15%	IFITM2 \| E1_Ab \| 12.35 \| 120.89%
340	HSPA8 \| E7_Da \| 12.14 \| 50.14%	HNRNPD \| E7_Da \| 12.24 \| 499.07%	LDHA \| E15_Ab \| 12.35 \| 96.41%
341	CKS1B \| E1_Ac \| 12.14 \| 350.06%	NCL \| E8_Da \| 12.24 \| 341.56%	RPS6 \| E4_Da \| 12.35 \| 57.30%
342	NDUFA13 \| E1_Ai \| 12.14 \| 1055.56%	LMNB1 \| E1_Ae \| 12.24 \| 761.80%	NPM1 \| E4_Dc \| 12.34 \| 110.77%
343	HLA-C \| E3_Ac \| 12.14 \| 209.25%	HLA-C \| E3_Ab \| 12.23 \| 175.16%	NDUFB2 \| E3_Ag \| 12.34 \| 2058.71%
344	MCM7 \| E1_Ae \| 12.14 \| 387.48%	UFC1 \| E3_Af \| 12.23 \| 670.36%	UBE2I \| E2_Ad \| 12.34 \| 666.79%
345	FXYD5 \| E1_Ae \| 12.13 \| 212.53%	SSBP2 \| E2_Aj \| 12.23 \| 1643.76%	IL2RG \| E2_Ai \| 12.34 \| 214.94%
346	NDUFS6 \| E1_Ad \| 12.13 \| 685.56%	LST1 \| E4_Dl \| 12.22 \| 635.07%	DNAJB6 \| E3_Ai \| 12.33 \| 2040.21%
347	EWSR1 \| E1_Al \| 12.13 \| 597.97%	CANX \| E3_Ai \| 12.22 \| 232.92%	AC073621.1 \| E1_Da \| 12.33 \| 10019.92%
348	SLC40A1 \| E4_Af \| 12.12 \| 509.55%	PTMA \| E8_Dg \| 12.22 \| 55.11%	HNRNPD \| E7_Da \| 12.33 \| 640.06%
349	SRP9 \| E1_Ad \| 12.12 \| 170.74%	AC092798.2 \| E1_Ab \| 12.22 \| 70305.55%	TUBA1C \| E5_Ac \| 12.33 \| 249.85%
350	RPS20 \| E1_Ah \| 12.12 \| 70.06%	COX5B \| E1_Ab \| 12.22 \| 528.99%	CTD-2192J16.15 \| E1_Da \| 12.32 \| 29810.49%
351	GNB2L1 \| E9_De \| 12.11 \| 125.61%	ITM2C \| E2_Ae \| 12.21 \| 207.32%	YBX1 \| E5_Ac \| 12.32 \| 108.40%
352	TIMM8B \| E1_Ac \| 12.11 \| 386.98%	DDX3X \| E19_Da \| 12.21 \| 458.06%	PDLIM1 \| E8_Db \| 12.32 \| 214.89%
353	GLUL \| E3_Dl \| 12.11 \| 498.95%	TRAM1 \| E1_Da \| 12.20 \| 290.20%	HLA-C \| E3_Ab \| 12.32 \| 175.96%
354	RPS15AP1 \| E1_Db \| 12.10 \| 75825.60%	HM13 \| E1_Ae \| 12.20 \| 633.62%	RPS24 \| E4_Da \| 12.32 \| 90.41%
355	LIMK2 \| E17_Da \| 12.08 \| 7750.75%	SOD1 \| E1_Da \| 12.20 \| 300.67%	GBP5 \| E1_Ab \| 12.32 \| 3552.16%
356	SERF2 \| E4_Ae \| 12.08 \| 254.89%	CXorf56 \| E7_Ab \| 12.19 \| 1831.08%	RPS15AP1 \| E1_Db \| 12.32 \| 97550.85%
357	TPM3 \| E11_Dc \| 12.08 \| 561.60%	TRA2A \| E3_Da \| 12.17 \| 597.25%	RPSA \| E4_Db \| 12.31 \| 173.17%
358	COX7A2L \| E2_Ae \| 12.08 \| 1088.08%	SF1 \| E1_Ah \| 12.16 \| 494.54%	ROMO1 \| E2_Db \| 12.31 \| 451.34%
359	RPL15 \| E1_Dl \| 12.08 \| 127.73%	PDIA3 \| E13_Ab \| 12.15 \| 168.93%	RPL13A \| E3_Db \| 12.31 \| 20.65%
360	HMGN2 \| E3_Dd \| 12.07 \| 55.75%	GNAS \| E21_Ab \| 12.15 \| 382.01%	BST2 \| E1_Ac \| 12.31 \| 290.49%
361	ENSA \| E1_Ai \| 12.07 \| 475.25%	RPL15 \| E1_Dk \| 12.15 \| 166.28%	HLA-DPA1 \| E3_Df \| 12.31 \| 182.25%
362	CDC20 \| E3_Da \| 12.07 \| 551.16%	SELL \| E3_Ab \| 12.15 \| 42.02%	ENSA \| E1_Ai \| 12.30 \| 596.66%
363	HNRNPH1 \| E3_De \| 12.07 \| 492.50%	SH2D3C \| E2_Da \| 12.15 \| 677.86%	GAS5 \| E3_Af \| 12.29 \| 1083.74%
364	RPS4X \| E6_Da \| 12.07 \| 32.53%	RPS6 \| E4_Da \| 12.14 \| 46.12%	HSP90AB1 \| E13_Ab \| 12.29 \| 52.65%
365	RALY \| E1_Ae \| 12.06 \| 513.49%	TMEM66 \| E4_Ad \| 12.14 \| 270.25%	SH3BGRL3 \| E1_Ad \| 12.29 \| 103.16%
366	CD34 \| E3_Ab \| 12.06 \| 350.80%	FKBP1A \| E7_Da \| 12.14 \| 139.41%	HMGN1 \| E3_Ak \| 12.29 \| 545.00%
367	GNB2L1 \| E9_Ad \| 12.06 \| 120.58%	SERP1 \| E7_Da \| 12.13 \| 537.98%	GNB2L1 \| E8_Af \| 12.29 \| 122.93%
368	HLA-B \| E1_Di \| 12.06 \| 145.01%	MSN \| E14_Db \| 12.13 \| 85.90%	LSP1 \| E14_Da \| 12.29 \| 283.26%
369	EIF3H \| E7_Da \| 12.05 \| 741.24%	UQCR10 \| E1_Da \| 12.13 \| 299.76%	RHOA \| E10_Da \| 12.28 \| 89.86%
370	HNRNPH1 \| E8_Af \| 12.05 \| 487.16%	RPL5 \| E8_Da \| 12.13 \| 170.26%	EIF4A2 \| E1_Aj \| 12.28 \| 411.89%
371	AC092798.2 \| E1_Da \| 12.05 \| 32482.27%	DNAJB6 \| E7_Db \| 12.13 \| 2500.82%	AC092798.2 \| E1_Ab \| 12.28 \| 893851.33%
372	RPSA \| E4_Db \| 12.04 \| 175.94%	NCL \| E8_Ac \| 12.12 \| 314.73%	CORO1A \| E6_Db \| 12.28 \| 121.83%
373	ARPC2 \| E9_Da \| 12.04 \| 589.38%	METTL7A \| E1_Da \| 12.12 \| 517.32%	TMED9 \| E1_Ac \| 12.28 \| 623.09%
374	RPSA \| E4_Da \| 12.04 \| 175.22%	RAB7A \| E6_Dc \| 12.12 \| 239.03%	EIF3H \| E12_Da \| 12.27 \| 802.29%
375	DNAJB6 \| E3_Ai \| 12.03 \| 1939.27%	GNAS \| E17_Ab \| 12.12 \| 373.89%	HMGB2 \| E3_Db \| 12.26 \| 205.22%
376	COX7C \| E1_Da \| 12.03 \| 159.68%	HMGB1 \| E5_Dd \| 12.11 \| 171.71%	HMGN2 \| E3_De \| 12.26 \| 48.52%
377	GNB2L1 \| E8_Af \| 12.02 \| 117.84%	HM13 \| E1_Ad \| 12.11 \| 595.20%	UBE2D3 \| E10_Da \| 12.26 \| 967.06%
378	TMED9 \| E1_Ac \| 12.02 \| 621.97%	BCKDHA \| E1_Da \| 12.10 \| 690.48%	RPL10 \| E6_Dg \| 12.25 \| 73.73%
379	HLA-B \| E1_Db \| 12.02 \| 141.61%	CD99 \| E1_Ad \| 12.10 \| 173.54%	RPL13AP5 \| E1_Ab \| 12.24 \| 3505.92%
380	TPI1 \| E7_Da \| 12.02 \| 223.18%	TPM3 \| E11_Dc \| 12.10 \| 592.99%	HLA-E \| E1_Ae \| 12.22 \| 182.50%
381	RPL31 \| E1_Ah \| 12.02 \| 4983.31%	EEF2 \| E11_Ab \| 12.09 \| 41.58%	TPM3 \| E11_Ah \| 12.22 \| 400.34%
382	MSN \| E14_Db \| 12.02 \| 99.53%	HLA-B \| E2_Da \| 12.09 \| 143.69%	CNBP \| E3_Da \| 12.21 \| 275.95%
383	EIF3H \| E12_Da \| 12.01 \| 721.13%	P4HB \| E4_Db \| 12.08 \| 165.16%	EIF3H \| E4_Ag \| 12.21 \| 770.53%
384	HNRNPH1 \| E7_Ad \| 12.01 \| 474.18%	PTMA \| E8_Dd \| 12.08 \| 49.98%	CIRBP \| E3_Db \| 12.21 \| 283.27%
385	PABPC1 \| E2_Df \| 12.01 \| 69.24%	HLA-C \| E3_Ac \| 12.07 \| 156.82%	NHP2 \| E1_Ae \| 12.21 \| 360.45%
386	H3F3A \| E5_Da \| 11.99 \| 144.25%	LAPTM5 \| E8_Dc \| 12.07 \| 56.12%	COX5B \| E1_Ab \| 12.20 \| 466.07%
387	HMGN1 \| E3_Ak \| 11.99 \| 486.23%	HMGN1 \| E3_Ak \| 12.06 \| 576.58%	FTH1 \| E1_Da \| 12.19 \| 103.52%
388	UBE2I \| E2_Ad \| 11.99 \| 623.14%	TUBA1C \| E5_Da \| 12.06 \| 311.34%	GNAI2 \| E13_Da \| 12.19 \| 383.58%
389	HSP90AB1 \| E13_Da \| 11.98 \| 35.90%	CKS1B \| E1_Ac \| 12.06 \| 450.11%	C4ORF3 \| E3_Da \| 12.19 \| 472.32%
390	C6orf48 \| E1_Af \| 11.98 \| 380.57%	RBM3 \| E2_Db \| 12.06 \| 272.70%	HNRNPH1 \| E3_De \| 12.18 \| 682.58%
391	HLA-E \| E1_Ae \| 11.97 \| 212.81%	PDDC1 \| E6_Af \| 12.06 \| 2873.83%	CTD-2192J16.15 \| E1_Ab \| 12.17 \| 26845.91%
392	CXorf56 \| E7_Ab \| 11.97 \| 2109.04%	LAIR1 \| E5_Da \| 12.05 \| 407.33%	RNF181 \| E1_Ae \| 12.17 \| 540.38%
393	SNX3 \| E5_Da \| 11.97 \| 324.35%	CNBP \| E2_De \| 12.05 \| 365.16%	GNB2L1 \| E9_Ad \| 12.17 \| 112.88%
394	ALDH1A1 \| E4_Ad \| 11.97 \| 563.13%	RBM39 \| E1_Ap \| 12.05 \| 1085.70%	NDUFS6 \| E1_Ad \| 12.17 \| 687.88%
395	CUTA \| E1_Ap \| 11.97 \| 426.51%	SNX3 \| E5_Da \| 12.04 \| 307.62%	RPL23 \| E7_Da \| 12.16 \| 87.57%
396	CPSF3L \| E4_Dc \| 11.95 \| 2535.17%	ATP5A1 \| E8_Da \| 12.04 \| 188.07%	GNB2L1 \| E5_Ab \| 12.16 \| 112.40%
397	SLC40A1 \| E4_Ad \| 11.95 \| 451.49%	MCM7 \| E3_Da \| 12.04 \| 420.10%	GAS5 \| E5_De \| 12.16 \| 986.18%
398	HLA-A \| E4_Ad \| 11.95 \| 147.19%	RHOA \| E10_Db \| 12.04 \| 114.08%	TUT1 \| E12_Db \| 12.16 \| 111.81%
399	POLR1D \| E6_Da \| 11.95 \| 757.93%	ZNF90 \| E18_Da \| 12.02 \| 6432.53%	CDC42 \| E8_Da \| 12.16 \| 240.68%
400	NONO \| E17_Ac \| 11.95 \| 160.08%	ROMO1 \| E2_Db \| 12.02 \| 435.07%	GNB2L1 \| E5_Ah \| 12.16 \| 112.03%
401	CIRBP \| E3_Db \| 11.94 \| 246.33%	CSTB \| E1_Ab \| 12.02 \| 414.08%	LGALS9 \| E3_Ab \| 12.15 \| 675.54%
402	UBE2D3 \| E10_Da \| 11.94 \| 977.82%	TPI1 \| E7_Da \| 12.02 \| 183.34%	SELL \| E7_Da \| 12.15 \| 35.27%
403	RPL30 \| E8_Db \| 11.94 \| 80.04%	NECAP2 \| E4_Da \| 12.01 \| 1676.27%	PABPC1 \| E2_Df \| 12.15 \| 71.39%
404	CNBP \| E3_Da \| 11.93 \| 276.17%	CANX \| E13_Da \| 12.01 \| 201.11%	ENO1 \| E10_Db \| 12.14 \| 58.42%
405	NHP2 \| E1_Ae \| 11.93 \| 348.31%	IFITM2 \| E2_Dc \| 12.00 \| 100.41%	CCNI \| E10_Da \| 12.14 \| 188.56%
406	S100A6 \| E3_Da \| 11.92 \| 309.45%	PABPC1P1 \| E2_Dd \| 12.00 \| 15454.84%	RPL21 \| E6_Da \| 12.14 \| 55.31%
407	NCL \| E8_Db \| 11.91 \| 183.54%	GNB2L1 \| E8_Af \| 11.99 \| 152.89%	PRDX1 \| E3_Da \| 12.13 \| 118.43%
408	CNBP \| E2_Df \| 11.91 \| 273.63%	NDUFA4 \| E1_Ac \| 11.99 \| 710.52%	PDLIM1 \| E8_Da \| 12.13 \| 188.55%
409	HNRNPD \| E3_Ae \| 11.91 \| 424.97%	HSP90B1 \| E7_Ab \| 11.98 \| 68.80%	PTMA \| E8_De \| 12.13 \| 51.63%
410	EIF3D \| E4_Da \| 11.91 \| 488.76%	HLA-B \| E1_Db \| 11.98 \| 132.70%	CKS1B \| E1_Ac \| 12.13 \| 438.01%
411	RPS15AP1 \| E1_Ac \| 11.91 \| 66618.41%	APEX1 \| E1_Da \| 11.96 \| 98.96%	NONO \| E17_Ac \| 12.12 \| 166.38%
412	GNAS \| E17_Ab \| 11.91 \| 367.54%	BSCL2 \| E1_Ad \| 11.96 \| 1047.22%	EEF2 \| E11_Ab \| 12.11 \| 51.86%
413	GNAS \| E21_Ab \| 11.91 \| 367.02%	NONO \| E17_Ac \| 11.96 \| 160.50%	ERGIC3 \| E15_Dd \| 12.11 \| 1284.35%
414	EEF2 \| E11_Ab \| 11.90 \| 47.60%	HLA-DPA1 \| E3_Dc \| 11.96 \| 281.88%	SH3BGRL3 \| E2_Dc \| 12.11 \| 90.76%
415	TUBA1C \| E5_Ac \| 11.90 \| 172.56%	STMN1 \| E7_Dd \| 11.96 \| 267.53%	SH2D3C \| E1_Ac \| 12.10 \| 859.03%
416	NDUFB2 \| E3_Ag \| 11.90 \| 1772.74%	MCM4 \| E16_Da \| 11.95 \| 612.14%	SNRPB \| E1_Ac \| 12.10 \| 296.07%
417	GNAS \| E21_Db \| 11.90 \| 364.56%	TUBA1B \| E4_Da \| 11.95 \| 22.83%	EIF3D \| E4_Da \| 12.10 \| 494.48%
418	RPL4 \| E10_Ac \| 11.89 \| 26.35%	CANX \| E23_Db \| 11.95 \| 192.94%	ZNF90 \| E18_Da \| 12.09 \| 7508.34%
419	APEX1 \| E5_Da \| 11.88 \| 100.04%	PARK7 \| E2_Ad \| 11.95 \| 284.78%	SSBP2 \| E2_Aj \| 12.09 \| 1272.97%
420	DDX3X \| E19_Da \| 11.88 \| 339.23%	TPM3 \| E7_Aj \| 11.94 \| 532.24%	SF1 \| E1_Ah \| 12.09 \| 632.41%
421	SOD1 \| E1_Da \| 11.88 \| 279.69%	YBX1 \| E5_Ac \| 11.94 \| 103.79%	GNAI2 \| E9_Ab \| 12.08 \| 355.98%
422	NDUFA4 \| E1_Ab \| 11.88 \| 432.41%	PKM2 \| E3_Da \| 11.94 \| 117.60%	SELL \| E7_Ab \| 12.08 \| 33.52%
423	HMGN2 \| E3_De \| 11.87 \| 48.50%	H2AFY \| E5_Da \| 11.94 \| 893.40%	TUBA4A \| E7_Dg \| 12.08 \| 1165.88%
424	GNB2L1 \| E5_Ab \| 11.87 \| 106.22%	PGK1 \| E11_Ab \| 11.94 \| 289.69%	GSTP1 \| E3_De \| 12.08 \| 76.13%
425	RPL8 \| E7_Ab \| 11.87 \| 41.67%	GNB2L1 \| E9_De \| 11.94 \| 147.20%	PGK1 \| E11_Ab \| 12.07 \| 330.08%
426	SNRPB \| E1_Ac \| 11.86 \| 248.84%	MCM5 \| E5_Da \| 11.93 \| 632.52%	HLA-DPA1 \| E3_Dd \| 12.07 \| 154.77%
427	MCM5 \| E5_Da \| 11.86 \| 570.58%	RPSA \| E4_Da \| 11.93 \| 200.12%	GNAS \| E21_Db \| 12.07 \| 409.35%
428	TCEB2 \| E5_Da \| 11.86 \| 118.45%	PKM2 \| E1_Ab \| 11.92 \| 116.14%	CTSD \| E1_Ac \| 12.07 \| 256.72%
429	HSPE1 \| E1_Ad \| 11.86 \| 238.16%	CCT3 \| E2_Ag \| 11.92 \| 418.54%	SNX3 \| E5_Da \| 12.07 \| 329.53%
430	PTMA \| E6_Db \| 11.85 \| 39.05%	MCL1 \| E3_Da \| 11.91 \| 246.29%	HLA-C \| E3_Da \| 12.06 \| 147.38%
431	UQCRC1 \| E2_Da \| 11.85 \| 611.40%	RPN2 \| E14_Ab \| 11.91 \| 151.69%	GNAS \| E11_Ag \| 12.06 \| 407.61%
432	HSP90AB1 \| E11_Dc \| 11.85 \| 32.66%	RPL21 \| E6_Da \| 11.91 \| 74.03%	HLA-A \| E4_Dd \| 12.05 \| 99.51%
433	ROMO1 \| E2_Db \| 11.84 \| 424.71%	RPS4X \| E6_Dc \| 11.91 \| 43.00%	EIF4A2 \| E2_De \| 12.05 \| 350.51%
434	RAB7A \| E6_Dc \| 11.84 \| 232.22%	CAP1 \| E6_Db \| 11.90 \| 331.09%	RPS20 \| E1_Ah \| 12.05 \| 69.11%
435	HLA-DQB1 \| E3_Ab \| 11.83 \| 2726.91%	ERGIC3 \| E15_Dd \| 11.90 \| 983.52%	GNB2L1 \| E3_Aq \| 12.04 \| 103.69%
436	RPL13AP5 \| E1_Ab \| 11.83 \| 1749.97%	RPS15AP1 \| E1_Ab \| 11.89 \| 33746.27%	RPS4X \| E6_Da \| 12.04 \| 30.23%